Lb Pharmaceuticals (LBRX) Accumulated Depreciation (2024 - 2026)

Lb Pharmaceuticals' Accumulated Depreciation history runs 3 years deep, the most recent figure standing at $502000.0 for Q1 2026.

• In Q1 2026, Accumulated Depreciation changed N/A year-over-year to $502000.0; the TTM figure through Mar 2026 stood at $502000.0 (changed N/A YoY), while the FY2025 annual figure was $420000.0, up 315.84% from the prior year.
• Accumulated Depreciation was $502000.0 for Q1 2026 at Lb Pharmaceuticals, up from $420000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $502000.0 in Q1 2026 to a low of $101000.0 in Q4 2024.
• Historically, Accumulated Depreciation has averaged $340000.0 across 3 years, with a median of $378500.0 in 2025.
• Biggest YoY gain for Accumulated Depreciation was 315.84% in 2025; the steepest drop was 315.84% in 2025.
• A 3-year view of Accumulated Depreciation shows it stood at $101000.0 in 2024, then jumped by 315.84% to $420000.0 in 2025, then gained by 19.52% to $502000.0 in 2026.
• The last three Accumulated Depreciation figures came in at $502000.0 (Q1 2026), $420000.0 (Q4 2025), and $337000.0 (Q3 2025), per Business Quant data.